GlassScriptPhysician profile
Santiago Restrepo
NPI 1225019003
$532,316.32
in general payments reported to CMS, 2019-2025
78 companies · $28K in 2025
The $28K reported for 2025 was more than what 94% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96K · 2020: $130K · 2021: $131K · 2022: $94K · 2023: $21K · 2024: $33K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $48K · Food and Beverage: $22K · Consulting Fee: $8,590 · Travel and Lodging: $3,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $48,002.50 |
| Food and Beverage | $22,163.30 |
| Consulting Fee | $8,590.00 |
| Travel and Lodging | $3,438.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $174,423.15 | 2019-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Lilly USA, LLC | $104,148.92 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Abbvie INC. | $93,328.13 | 2021-2025 | |
| Allergan, INC. | $55,978.17 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $23,976.77 | 2021 | |
| Pfizer INC. | $15,272.82 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14,667.05 | 2022 | |
| Ucb, INC. | $8,972.69 | 2019-2025 | Rystiggo, Briviact, Nayzilam |
| Catalyst Pharmaceuticals, INC. | $6,626.42 | 2019-2025 | Firdapse |
| Lundbeck LLC | $6,595.13 | 2019-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $2,417.34 | 2019-2025 | Nuplazid |
| Argenx US, INC. | $2,248.37 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurocrine Biosciences, INC. | $1,796.36 | 2019-2025 | Ingrezza, Ongentys |
| Eli Lilly and Company | $1,600.00 | 2022 | |
| Neurelis, INC. | $1,287.60 | 2020-2025 | Valtoco |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,224.57 | 2019-2025 | Infinity, Proclaim |
| Eisai INC. | $1,086.51 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $1,013.09 | 2019-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Nevro Corp. | $922.43 | 2019-2023 | Senza |
| Medtronic, INC. | $830.11 | 2021-2025 | Percept PC Brainsense, Sensight |
| Acorda Therapeutics, INC | $786.66 | 2019-2024 | Inbrija, Ampyra |
| Emd Serono, INC. | $783.77 | 2019-2022 | |
| Axsome Therapeutics, INC. | $780.88 | 2024-2025 | Auvelity, Symbravo, Sunosi |
| Kyowa Kirin, INC. | $773.31 | 2019-2024 | Nourianz |
| Ge Healthcare | $730.44 | 2019-2025 | |
| Assertio Therapeutics, INC. | $717.07 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $685.61 | 2019-2022 | |
| Mdd US Operations, LLC | $666.37 | 2020-2025 | Gocovri, Gocovri, Apokyn |
| Alexion Pharmaceuticals, INC. | $646.90 | 2019-2025 | Ultomiris |
| Amgen INC. | $621.85 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $528.74 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $509.50 | 2019-2025 | Qelbree |
| Csl Behring | $415.23 | 2019-2025 | Hizentra |
| Upsher-Smith Laboratories LLC | $400.05 | 2019-2023 | |
| Grifols USA, LLC | $378.28 | 2022-2025 | Gamunex-C |
| Octapharma USA, INC. | $357.13 | 2022-2025 | Panzyga, Octagam Immune Globulin (Human), Cutaquig |
| Sk Life Science, INC. | $294.89 | 2020-2025 | |
| Corium, LLC | $271.46 | 2022-2023 | Adlarity |
| Adamas Pharmaceuticals, INC. | $266.70 | 2019-2021 | |
| Biogen, INC. | $263.71 | 2019-2025 | Skyclarys, Leqembi, Vumerity |
| Averitas Pharma INC. | $240.58 | 2023-2025 | Qutenza |
| Amylyx Pharmaceuticals, INC. | $231.18 | 2023-2024 | Relyvrio |
| Janssen Biotech, INC. | $224.76 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $221.66 | 2020-2025 | Hyqvia, Gammagard |
| Otsuka America Pharmaceutical, INC. | $208.42 | 2023-2025 | Nuedexta, Rexulti |
| Tanabe Pharma America, INC. | $191.16 | 2020-2025 | Radicava |
| Medtronic USA, INC. | $161.35 | 2020 | |
| Avion Pharmaceuticals | $140.15 | 2022-2023 | Dhivy |
| Merz Pharmaceuticals, LLC | $139.89 | 2021-2025 | Xeomin, Inbrija |
| Canon Medical Systems USA, INC. | $127.12 | 2019 | |
| Azurity Pharmaceuticals, INC. | $110.87 | 2023-2024 | Horizant, Horizant |
| Alnylam Pharmaceuticals INC. | $106.60 | 2021-2024 | Onpattro |
| Merz North America, INC. | $103.22 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $85.48 | 2023-2024 | Ztlido |
| Grt US Holding, INC. | $71.82 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $71.35 | 2023 | Aptiom |
| Shire North American Group INC | $51.69 | 2019 | |
| Jazz Pharmaceuticals INC. | $49.89 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $45.48 | 2025 | Wainua |
| Livanova USA, INC. | $43.88 | 2019 | |
| Vertical Pharmaceuticals, LLC | $39.41 | 2019 | |
| Harmony Biosciences LLC | $38.93 | 2022 | |
| Validus Pharmaceuticals LLC | $36.36 | 2023 | Equetro |
| Life Molecular Imaging LTD | $31.18 | 2021-2025 | Neuraceq |
| Springworks Therapeutics, INC. | $28.23 | 2025 | Gomekli |
| Dynasplint Systems INC. | $26.13 | 2025 | Dynasplint |
| Microtransponder, INC. | $25.30 | 2025 | |
| Promius Pharma LLC | $24.62 | 2019 | |
| Mallinckrodt Hospital Products INC. | $17.84 | 2021 | |
| Amarin Pharma, INC. | $17.42 | 2021 | |
| Xeris Pharmaceuticals, INC. | $17.34 | 2025 | Keveyis |
| Arbor Pharmaceuticals, INC. | $16.38 | 2019 | |
| Tonix Medicines, INC. | $14.61 | 2025 | Zembrace Symtouch |
| Aprecia Pharmaceuticals, LLC | $13.02 | 2023 | Spritam |
| Currax Pharmaceuticals LLC | $12.38 | 2022 | |
| Zyla Life Sciences, INC. | $12.26 | 2019 | |
| Aucta Pharmaceuticals, INC. | $12.18 | 2025 | Motpoly Xr |
| Almatica Pharma LLC | $12.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Santiago Restrepo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.